Stay updated with breaking news from Sisaf Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SiSaf Ltd, an RNA therapeutics company, is pleased to announce the publication in the peer-reviewed journal Molecular Therapy Nucleic Acids(1) of positive in vivo data demonstrating the safety and efficacy of its siRNA therapy for Autosomal Dominant Osteopetrosis 2 (ADO2). The data reported in the paper demonstrate ...
SiSaf Appoints Nikos Tzagkarakis in the New Role of Chief A.I. Officer Guildford, England – 13 July 2023 – RNA delivery and therapeutics company SiSaf Ltd announces that it has appointed Nikos Tzagkarakis in the newly created role of Chief A.I. Officer. The new position reflects the...
GUILDFORD, England, July 13, 2023 (GLOBE NEWSWIRE) -- RNA delivery and therapeutics company SiSaf Ltd announces that it has appointed Nikos Tzagkarakis in the newly created role of Chief A.I. Officer. The new position
GUILDFORD, United Kingdom, March 02, 2023 (GLOBE NEWSWIRE) -- RNA delivery and therapeutics company SiSaf Ltd today announces its collaboration with the...
SiSaf Ltd, an RNA delivery and therapeutics company, is pleased to announce positive data confirming safety and efficacy of its Bio-Courier™ next generation silicon stabilized hybrid lipid nanoparticles (sshLNP) as an effective non-viral delivery system for Autosomal Dominant Osteopetrosis 2 (ADO2) siRNA ...